New research suggests that taking paracetamol during pregnancy does not increase the risk of autism, ADHD, or developmental issues in children. The study, published in a major medical journal, analyzed 43 robust studies involving hundreds of thousands of women and found no link between paracetamol use and increased risk of these conditions.
The findings contradict claims made by US President Donald Trump last year that paracetamol "is no good" for pregnant women and should be avoided. Trump's comments were widely criticized by medical organizations worldwide, who pointed out that the evidence for any potential harm was limited and inconclusive.
According to Professor Asma Khalil, lead study author and consultant obstetrician, "There is no link, there is no association, there's no evidence that paracetamol increases the risk of autism." The review also found that studies with a low risk of bias and those that followed children for more than five years showed no link between paracetamol use and increased risk of these conditions.
The study's findings have been welcomed by medical experts, who say they will help reduce worry among expectant mothers. However, US health officials continue to express concern over the potential risks of paracetamol during pregnancy, citing "many experts" who have raised concerns about its safety.
In contrast, health organizations in the UK and Europe have long recommended paracetamol as a safe option for pregnant women when taken as directed. The study's lead author notes that paracetamol is often the first-line medication recommended for pregnant women in pain or with a fever, and that it remains the safest painkiller available.
The review has also shed light on the complex nature of autism, which experts say is likely the result of a mix of genetic and environmental factors. The study's findings suggest that paracetamol use may not be one of these contributing factors, at least in terms of increased risk of autism or other developmental issues.
The findings contradict claims made by US President Donald Trump last year that paracetamol "is no good" for pregnant women and should be avoided. Trump's comments were widely criticized by medical organizations worldwide, who pointed out that the evidence for any potential harm was limited and inconclusive.
According to Professor Asma Khalil, lead study author and consultant obstetrician, "There is no link, there is no association, there's no evidence that paracetamol increases the risk of autism." The review also found that studies with a low risk of bias and those that followed children for more than five years showed no link between paracetamol use and increased risk of these conditions.
The study's findings have been welcomed by medical experts, who say they will help reduce worry among expectant mothers. However, US health officials continue to express concern over the potential risks of paracetamol during pregnancy, citing "many experts" who have raised concerns about its safety.
In contrast, health organizations in the UK and Europe have long recommended paracetamol as a safe option for pregnant women when taken as directed. The study's lead author notes that paracetamol is often the first-line medication recommended for pregnant women in pain or with a fever, and that it remains the safest painkiller available.
The review has also shed light on the complex nature of autism, which experts say is likely the result of a mix of genetic and environmental factors. The study's findings suggest that paracetamol use may not be one of these contributing factors, at least in terms of increased risk of autism or other developmental issues.